Regen BioPharma Inc (RGBP)

[SidVicious]

David Koos has no relationship with Lilly. This misinformation needs to stop. All Regen did is participate in an open innovation program that allowed any biotech to participate. That program shut down long ago and nothing came of it.

This is the PR: https://www.prnewswire.com/news-releases/regen-biopharma-inc-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-and-company-585014641.html

The terms are boiler plate for any company that participated in the program. The problem is that over zealous message board posters purposely spun this to mean there was some special deal with Lilly and many naïve investors believed the lie.

This was in 2016. It is now 2023 and Lilly did not find anything of interest in what Regen was doing to warrant any type of partnership. And even if they did, no big pharma partners with a suspect OTC biotech run by a shady CEO.

I wrote about this back then.

It is quire funny and sad that so many still do not want to come to accept the fact that they bought into a false narrative created by a few to do what is common with OTC stocks. That is something that rhymes with lump and stump.

And let us know if Dooshbag Dave responds to your email